Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

SEREVELLE safely and effectively promotes hair growth in adults with thinning hair.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Combining hyaluronic acid and oxygen may help improve urinary incontinence in menopausal women.

Most women had adequate essential elements except zinc, and lead levels were higher in peri-/post-menopausal women.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Chemotherapy can harm kidneys in breast cancer patients.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Many women in Recife lack understanding of the climacteric period, needing better education and care.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Sex hormones do not cause oral lichen planus.

Oral lichen planus is not linked to sex hormone levels.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

Personalized supplements are important for women's health, but hormone therapy can increase cancer and heart risks.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.